Correlation Between Home Depot and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both Home Depot and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Home Depot and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Home Depot and Tscan Therapeutics, you can compare the effects of market volatilities on Home Depot and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Home Depot with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Home Depot and Tscan Therapeutics.
Diversification Opportunities for Home Depot and Tscan Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Home and Tscan is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Home Depot and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Home Depot is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Home Depot are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Home Depot i.e., Home Depot and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between Home Depot and Tscan Therapeutics
Allowing for the 90-day total investment horizon Home Depot is expected to generate 0.31 times more return on investment than Tscan Therapeutics. However, Home Depot is 3.23 times less risky than Tscan Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.11 per unit of risk. If you would invest 40,289 in Home Depot on August 27, 2024 and sell it today you would earn a total of 1,711 from holding Home Depot or generate 4.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Home Depot vs. Tscan Therapeutics
Performance |
| Timeline |
| Home Depot |
| Tscan Therapeutics |
Home Depot and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Home Depot and Tscan Therapeutics
The main advantage of trading using opposite Home Depot and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Home Depot position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.The idea behind Home Depot and Tscan Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |